2,2'-(Cyclohexa-2,5-diene-1,4-diylidene)dimalononitrile, 95.0%, 5g

Nimodipine, >98%, 100mg

2-(4-Bromo-pyrazol-1-yl)-pyridine, 97.0%, 1g

2,4-dimethyl-5-(1H-pyrazol-3-yl)-1,3-thiazole, 5g

2-(1-(TERT-BUTOXYCARBONYL)-3-METHYLAZETIDIN-3-YL)ACETIC ACID, 95.0%, 5g

4-iso-Butoxybenzonitrile, 97.0%, 250mg

3-(2-Chloroethyl)quinazoline-2,4(1H,3H)-dione, 95.0%, 5g

tert-Butyl-4-bromobutanoate, 97.00%, 100g

250 ml round bottle HD/LD PE white RD 32 cylindrical

4-Ethyl-2-nitroaniline, 97%, 100mg

Ethyl 4-(4-Chloro-3-fluorophenyl)-4-oxobutanoate, 97.0%, 1g

1-(4-methylphenyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, 95.0%, 500mg

4-Methyl-1-(4-nitrophenyl)piperidine, 100g